Clinical Trial Update: the Blood-Aqeous Barrier During Anti-Angiogenic Therapy in Exudative Age-Related Macular Degeneration [NA]

View source ↗

Summary

A completed clinical trial studied how anti-angiogenic therapy impacts the blood-aqueous barrier in exudative age-related macular degeneration. The snippet does…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Snippet

Sponsor: The Filatov Institute of Eye Diseases and Tissue Therapy | Conditions: AMD | NA | Status: COMPLETED